Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

Vectura Group Plc

Sector: Pharmaceutical Preparations Region: United Kingdom


Exchange/Ticker: London Stock Exchange: VEC


Company Description

Vectura Group Plc manufactures novel therapeutic products and drug delivery systems. It engages in developing inhaled therapies principally for the treatment of respiratory diseases. The company's main products target diseases such as asthma and chronic obstructive pulmonary disease. It is engaged in a single business activity of pharmaceuticals, which consists of the research, development and commercialisation of pharmaceutical products. The company was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom.

Similar to: BioGaia AB, GW Pharmaceuticals Plc, Mast Therapeutics, Inc.

Featured Company


Aben Resources Ltd.

Vancouver, BC, CA

Aben Resources (TSX.V: ABN) is a Canadian gold and silver exploration company with a focus on developing properties in the Yukon.… Learn more →

You may also be interested in:


Mast Therapeutics, Inc.

San Diego, CA, US

Mast Therapeutics, Inc. is a publicly traded biopharmaceutical company headquartered in San Diego, California. The Company is leveraging… Learn more →

GW Pharmaceuticals Plc

Salisbury, WI, GB

GW Pharmaceuticals Plc researches and develops cannabinoid medicines. The companys principal activity is developing and manufacturing… Learn more →

BioGaia AB

Stockholm, SE

BioGaia develops, markets and sells probiotic products with documented health benefits. Its products are primarily based on different… Learn more →